Patient Protection and Affordable Care Act of 2010 and children and youth with special health care needs

Journal of Developmental and Behavioral Pediatrics : JDBP
Heidi M FeldmanIrene M Loe

Abstract

The Patient Protection and Affordable Care Act (ACA) was designed to (1) decrease the number of uninsured Americans, (2) make health insurance and health care affordable, and (3) improve health outcomes and performance of the health care system. During the design of ACA, children in general and children and youth with special health care needs and disabilities (CYSHCN) were not a priority because before ACA, a higher proportion of children than adults had insurance coverage through private family plans, Medicaid, or the State Children's Health Insurance Programs (CHIP). ACA benefits CYSHCN through provisions designed to make health insurance coverage universal and continuous, affordable, and adequate. Among the limitations of ACA for CYSHCN are the exemption of plans that had been in existence before ACA, lack of national standards for insurance benefits, possible elimination or reductions in funding for CHIP, and limited experience with new delivery models for improving care while reducing costs. Advocacy efforts on behalf of CYSHCN must track implementation of ACA at the federal and the state levels. Systems and payment reforms must emphasize access and quality improvements for CYSHCN over cost savings. Developmental-behavior...Continue Reading

References

Aug 26, 1998·Pediatrics·M McPhersonB Strickland
Jan 5, 2005·Archives of Pediatrics & Adolescent Medicine·Paul W Newacheck, Sue E Kim
Jul 29, 2005·The New England Journal of Medicine·Lynn M OlsonPaul W Newacheck
Jan 11, 2007·Pediatrics·Donald P OswaldMelinda B Moore
Mar 7, 2007·Health Affairs·Neal HalfonMoira Inkelas
Oct 17, 2008·Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association·Amy CassedyPaul W Newacheck
Dec 9, 2008·American Journal of Public Health·Daniel J PilowskyDeborah S Hasin
May 1, 2009·Pediatrics·Paul W NewacheckJames M Perrin
Sep 8, 2010·The New England Journal of Medicine·Michael D KoganPeter C van Dyck
Oct 15, 2011·International Journal of Clinical Practice·C WendtN Reibling
Nov 19, 2011·Health Services Research·Michael E Chernew
Jan 6, 2012·Journal of Developmental and Behavioral Pediatrics : JDBP·Nathan J Blum, UNKNOWN DBPNet Steering Committee
Mar 28, 2012·Medical Care Research and Review : MCRR·Embry M Howell, Genevieve M Kenney
Apr 13, 2012·The New England Journal of Medicine·Zirui Song, Bruce E Landon
Jan 3, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·John M RollDonelle Howell
Feb 15, 2013·The New England Journal of Medicine·Eric C Stecker
Mar 30, 2013·Clinical Pediatrics·Jean L Raphael, Angelo P Giardino
Apr 3, 2013·JAMA Pediatrics·Charles J Homer, Kavita K Patel
May 6, 2014·JAMA : the Journal of the American Medical Association·Tina L ChengNeal Halfon

❮ Previous
Next ❯

Citations

Jan 6, 2016·Maternal and Child Health Journal·Myra Rosen-ReynosoJudith Palfrey
Sep 15, 2020·Medical Care·Hanadi Y HamadiAaron C Spaulding
Sep 26, 2021·Journal of Perinatology : Official Journal of the California Perinatal Association·Ashwini LakshmananCynthia L Gong

❮ Previous
Next ❯

Software Mentioned

DBPNet

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.